Nuclear Power Corporation Of India Limited tender RABIES VACCINE INJ. TENECTEPLASE 40 MG 2026

Tender Overview

Nuclear Power Corporation Of India Limited (Department Of Atomic Energy) invites bids for the supply of Goods in India, with the scope limited to delivery of specified injectables. The procurement leverages a flexible quantity clause allowing up to 25% increase of bid/contracted quantities, at existing rates, and delivery timing adjustments tied to the original/extended delivery periods. The tender emphasizes GST handling by bidders, mandating invoices in the consignee’s name with the consignee GSTIN. No BOQ items are listed, indicating a straightforward supply contract rather than a multi-line equipment kit. The opportunity is characterized by a pure procurement of goods, without installation or service components, under a framework that accommodates price adjustments via discounts and potential contract termination for non-performance. Location is stated as India, with procurement scope centered on medical injectables including rabies vaccine/human formulations and related products. This tender presents a controlled, single-entity supply opportunity with strict invoicing and compliance expectations, and the seller remains liable for performance notwithstanding assignment or subcontracting. The description implies an emphasis on compliance, traceability, and timely delivery to a government facility.

Technical Specifications & Requirements

• Scope of supply: Only supply of Goods (no services)
• GST handling: Bidder bears GST applicability; reimbursement capped to quoted rate or actuals, whichever lower
• Invoicing: Invoice must be in the consignee’s name with the consignee’s GSTIN
• Price variability: Quantity may increase by up to 25% during contract and/or option period
• Delivery timing: Extended delivery period calculations based on original/extended delivery duration with a minimum 30 days
• Assignment/Sub-contracting: Requires buyer’s written consent; joint liability remains with seller
• Termination rights: Buyer can terminate for non-compliance or delivery failures
• Document alignment: No BOQ details provided; bidders should ensure compliance with general procurement terms
• Category: Pure supply of injectable goods (medication), consistent with government medical procurement norms
• No technical specs provided: Emphasizes compliance, traceability, and contract integrity

Terms, Conditions & Eligibility

• GST/Invoices: Bidder to handle GST; invoicing in consignee name with consignee GSTIN; GST reimbursement up to quoted rate or actuals
• Quantity flexibility: Up to 25% additional quantity at contracted rates; delivery timing adjusted per option clause
• Assignment/Sub-contracting: Not allowed without prior written consent from buyer; joint liability persists
• Delivery risk & termination: Buyer may terminate for failure to deliver or breach of material terms, or insolvency events
• Payment and price adjustments: Price adjustments permissible via discounts or remedies; no explicit payment schedule provided
• Documentation: No BOQ; focus on generic tender compliance and GST documentation
• Seller obligations: Must adhere to delivery schedule from the date of final order; ensure shipping in the required timeline
• Compliance: Must meet government procurement standards and ensure product authenticity